Yana Terleeva, head of the Ukranian Ministry of Health’s TB programme

Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder of 2022. 

This month, Teerleva had been planning to implement an innovative new TB treatment regimen to further step up the national response to its drug resistant TB burden – which TB control officials in Geneva had praised as a model. 

“Instead we are dealing with the Russian invasion and discussing military hardware”, Teerleva said in a media briefing Tuesday, just ahead of World Tuberculosis Day, 24 March.

Global TB experts are bemoaning the destruction of Ukraine’s innovative TB programme, which had made significant progress in addressing the country’s high burden of multi-drug resistant TB (MDR-TB) over the past 15 years. 

Meanwhile, with global TB funding well below needs, prospects of meeting the UN Sustainable Development Goal target for ending the TB epidemic by 2030 look increasingly dim, Lucica Ditui, executive director of the Geneva-based STOP TB Partnership, told Health Policy Watch in an interview.

“This gives us very little chance of meeting the UN 2030 targets,” she said.

Model programme now in ashes – literally

Almost one-third of Ukraine’s TB cases are drug-resistant, and last year the country diagnosed and treated 24,000 people with TB, including almost 5,000 people with MDR-TB.

But the Ukrainian government had been “extremely committed” to addressing TB over the past two to three years, paying for new drugs and diagnostics and building strong relationships with civil society organisations, Ditiu told Health Policy Watch.

“The country did a lot to improve their health system. It is devastating to see these bombs destroying everything. These are losses that will take decades to regain.” 

A doctor shows Oleg Chutvatov, who was receiving TB treatment at the hospital in Kharkiv, an x-ray photo of his lungs in July 2021. The city is now under heavy attack from the Russian invasion.

Over the past 15 years, Ukraine had significantly reduced its TB cases from over 127 cases per 100 000 people in 2005 to just 42.2 cases per 100 000 people in 2020.

Just before the war, says Ditiui, “The country was paying for their own TB drugs as well as diagnostics – and they had secured enough to treat and diagnose everyone in need in Ukraine.

“They were very keen to implement new tools like rapid molecular diagnosis, as well as new drugs.  They had cohorts of people enrolled in studies for new TB treatments. Collaboration between public health officials, civil society and communities also was very good.”

The gains in TB treatment were part of a broader health sector reform that had been underway, Ditiu added, saying: “What I am really upset about is that the country did a lot to improve their health system, their hospitals, to do health sector reform. To see these bombs destroying everything. These are losses that will take decades to regain.”

“Ukraine was always at the forefront of the fight against tuberculosis,” Teleeva told the Stop TB briefing Tuesday. “We wanted Ukraine and the entire world to be free from the TB and for that, we have done everything possible.”

However, she said that according to health ministry information, “more than 135 hospitals in Ukraine have been shelled by the Russian aggressors”, including “three huge regional anti-tuberculosis dispensaries” and the country’s health infrastructure “is not working”.  WHO has confirmed some 60 attacks on hospitals and other health facilities. 

Appeal to combat stigma – among the war’s knock-on effects

Both Ditiu and Teeleva stressed the need to focus now on countering the knock-on effects of the war – including how to treat internally displaced people, how to ensure people fleeing can continue their medications, and how to combat stigma that refugees elsewhere may encounter.

 “We worked to overcome the stigma discrimination of these people living with TB”, Teleeva said, of the pre-war period. 

She appealed to neighbouring countries that have a much lower burden of TB disease not to stigmatise Ukrainian refugees. 

“TB is very sensitive, and if we broadcast information about its uncontrolled spread, we will stigmatize people who are already stigmatized, for people who are already in a very difficult situation,” said Terleeva. 

Ditiu acknowledged that it’s very likely the war will lead to a higher level of TB cases -particularly inside Ukraine itself. “We’ll see an increase in TB, in drug-resistant TB and in mortality,”  she predicted, “because people will be staying close together in shelters, in crowded places, with bad food and stress.”

However, she said good tracking and surveillance by countries that receive refugees can help counter any spillover effect, beyond the borders.

‘Stupid war’

Romania’s Health Minister, Prof Alexandru Rafila

Decrying the “stupid war”, Romania’s Health Minister, Professor Alexandru Rafila, told the briefing that his country was doing everything it could to assist the refugees that had fled across the 600km border with his country, including identifying and ensuring treatment for TB patients.

As a country with a relatively high burden of TB itself, Romania has “a network of TB hospitals and TB ambulatory care centres where we can perform rapid diagnosis and treat Ukrainian patients if they are resistant or need to initiate treatment”, added Rafila.

The Global Fund has also provided Romania with additional Gene Xpert rapid testing machines and TB medication to assist Ukranian patients, the health minister added.  

However, while Romania and Moldova had “some capacity” to deal with TB, Ditiu warned that Poland is in a different category – precisely because its own burden is quite low.

“Poland is not a country with a lot of TB – so I’m not sure how well the network will be able to deal with it – even though the doctors certainly have a lot of knowledge”.

In addition, prices of TB medication in both Romania and Poland are up to ten times higher than in Ukraine, as both countries are part of the European Union and pay EU prices for drugs that Ukraine was able to procure through the Global Fund, Ditiu added. 

“We are having a conversation with the Global Fund to see how we can lower the cost,” she added. 

TB civil society trying to locate patients

Olya Klymenk, head of TB People Ukraine, a network of over 70 organisations, said that her organisation was doing its best to locate displaced patients who have fled their homes or their communities, and offer them humanitarian aid, including food.

“We are trying to take care of the patients who are out of the hospital right now because we understand that, without social support, they will not have a good life,” said Klymenk.

Teleeva stressed that in the emergency the primary need is to, “focus on ensuring patients know where to go and have a desire to continue treatment.

“They have to be assured there is a reason to live, that they will go back to Ukraine, and they have to be healthy to help us rebuild. They need this optimism, to have this desire to live and continue living.”

‘Pathetic’ investment in TB

Dr Lucica Ditiu, Executive Director of the Stop TB Partnership

Meanwhile, Ditiu lamented that “investments in TB are pathetically low” – perhaps because 90% of the disease burden is in lower-income countries.

“In 2020, we had $1.9 billion [in] domestic investments, which is very very, very little,” she said, referring to national governments’ own contributions to beating TB. In addition, “The Global Fund, which is a big donor for TB, gave around $800 million, which is completely insufficient.” 

Stop TB estimates that $19.6 billion per year will be needed over the next eight years for TB prevention and care, and $4 billion per year will be required for research and development (R&D) of the new diagnostics, medicines and vaccines needed to end TB. 

This represents about four times what is currently available for the TB response (in 2020, $5.3 billion was available for care and prevention and $0.9 billion for R&D).

The year 2022 is critical for the global fight to end TB as the world faces a fast-running countdown to reaching the 2018 United Nations High-Level Meeting (UNHLM) TB targets, which the international community agreed to meet by the end of December. All projections show that the world is not on course to meet the UNHLM treatment targets set for 2022.

“We simply cannot continue to stand on the sidelines and watch while people around the world fall ill and die from a preventable and treatable disease,” said Ditiu.

“We also cannot continue to accept what we accepted for years—every year having less than 40% of the funding need for the TB response. Now we are facing a disastrous funding shortfall, bigger than what we had expected. We not only need to step up efforts to meet targets set at the 2018 United Nations High Level Meeting on TB,” she said, referring to the UN pledge to accelerate progress toward the 2030 targets, “but the TB response must also recover from the devastating impacts of the COVID-19 pandemic.”

Image Credits: The Global Fund / Evgeny Maloletka.

Special Olympics, Switzerland 2022

The weekend of 12-13 March was a glorious time to be in the Swiss mountain resort of Villars-sur-Ollon post-pandemic. Special Olympics Switzerland had organized the regional games sporting competition with skiing, bowling, tennis and boccia, drawing dozens of keen athletes and supporters.

My son joined the other 46 skiers and snowboarders from the region to compete, racing at their top speeds in the ski slalom. It was a weekend full of sporting passion and the best apres-ski ever (dancing after the awards ceremony – with no need for alcohol to shake the booty!). I was so proud of my son who won a gold and of all the other athletes, parents and supporters. Everyone left with a smile, oblivious to the wars in the world.

World Down Syndrome Day

Fast forward a week later to 21 March, World Down Syndrome Day – which we celebrated with events at the United Nations in Geneva and New York City. It’s a day dedicated to people like my son who are born with an extra chromosome. An iconic symbol of the day is the LotsOfSocks campaign, which uses the symbol of mismatched socks as a takeoff point for talking about the needs and rights of people around the world living with Down syndrome.  

In many high and middle-income countries, the proportion of babies born with Down syndrome (also called Trisomy 21)  has decreased in recent years  – due to rising rates of fetal screening of pregnant women of all ages.

According to the European Down Syndrome Association, there are about 417,000 people living with Down syndrome today, while annual live births of Down syndrome babies have averaged around 8,000 – “which would have been around 17,331 births annually, absent selective terminations”. Estimate termination rates, however, still vary widely from 83% in Spain to 0% in Malta

With the decline in numbers, the broad public awareness about Down syndrome accumulated over the past half-century, and the recognition that people living with Down syndrome can live full, rewarding lives seems to be fading as well. 

While in some countries, as well as US states, a mother’s right to terminate her pregnancy is sharply limited by law, as part of broader restrictions in abortion rights being fiercely debated as we speak. In others, the question posed by many doctors is not if, but when, the pregnancy will be terminated.

But regardless of the law and ethics around those thorny issues – the question looms even larger for me is the enabling environment – or lack thereof – which we can offer to those children and adults with Down syndrome that are alive now, and will continue to be born regardless.  As the mother of a child living with Down syndrome in high-income Switzerland, the feeling is sometimes that we are part of a group that society would prefer to forget or not see. Lost socks. 

Down syndrome is not going to disappear 

To begin with, outside of Europe and other high-income countries – we lack good estimates of how many babies with Down syndrome are born every year, and how many people with Down syndrome are living in the world today. 

This is despite the fact that Down syndrome is perhaps the most common genetic abnormality to appear right at birth.  Information about the proportion of live births of babies with Down syndrome annually is wildly at variance too, ranging  from as low as one in 700 to as high as 1 in 1000-1,100 – with the latter estimates culled from a  factsheet of the US Centers for Disease Control citing a now-defunct World Health Organization website on genomics and a United Nations webpage on World Down Syndrome Day 2020 – which then proceeds to make the wildly impossible estimate that: “Each year, approximately 3,000 to 5,000 children are born with this chromosome disorder”. 

This is when in fact 6,000 babies with Down Syndrome are born every year in the United States alone.  

So doing the math as a layperson, globally there are 140 million live births per year.  If we take the Down Syndrome International estimate that on average 1 in 800 live births are babies born with Down syndrome, this leaves us with 175,000 new babies with Down syndrome born every year. That’s a lot of extra chromosomes that are not going to disappear anytime soon!

Add to that some other observations of likely trends.  In many lower-income countries, as in wide swathes of Europe, the simple, prenatal blood tests that can identify Down syndrome are not routinely offered to women, and may not even be available. 

And in many other LMICs, termination of birth may be inaccessible, stigmatized or  forbidden by national laws – as is the case in many upper-income countries as well. 

Countries in Europe that offer Non-Invasive Prenatal screening Tests (NIPT) for pregnant women to identify Down syndrome. (Note: the test is universally offered in Switzerland as well): Nature 2021

So while it is likely that the proportion of people with Down syndrome may slowly shift in coming decades to become more of a low- and middle-income country issue, the condition is not going to go away. 

And even as access to pre-natal screening increases worldwide, some parents will still choose to bring a child with Down syndrome into this world. In making that choice, they should not be forced to abort due to a lack of awareness about the condition or options for their child to live a rich, meaningful and fulfilled life.  

Like any other rare conditions, the measure of our compassion as a society is also measured in our ability to nurture and care for the most vulnerable – including those with genetic conditions such as Down syndrome.  Enough is enough, stop the ignorance and discrimination. 

Misinformation sets stage for stereotyping 

Awareness about Down syndrome and its implications is the first step towards creating the enabling conditions for a baby with Down syndrome to grow and thrive. 

Unfortunately, such awareness is limited – even in seats of global health leadership like Geneva. 

A search on the website of the World Health Organization (WHO) for information about Down syndrome – beyond the link to the now deceased page on genomics already mentioned, turns up just one two-page explainer – which is, astonishingly, more than half a century old. 

The document, from a 1966 edition of the Bulletin of the World Health Organization states that:   “Down’s syndrome is probably the most common of the severe developmental disorders which permit survival after birth.” However it goes on to add that:  “….The mortality in childhood is very high, and it is likely that about half of those born alive die by 10 years of age.”

If that were the case today, my son would have been dead five years ago. In fact, the average life expectancy today in a high-income country with supportive medical care is approximately 60 years – a huge increase from age 25 in only 1983.  

The United States CDC fact sheet on Down syndrome does little better. It is housed on a page describing birth defects – which is not technically correct.  Down syndrome is a genetic condition – the result of a naturally occurring chromosomal arrangement

What needs to be done? 

Clearly better information is a first condition for raising awareness about Down syndrome.  For starters, I suggest that both the United Nations, WHO and CDC scrutinize, fact-check and update their pages!

At the same time, there are a number of robust, worldwide and regional movements of parents and specialists which can provide better resources. These include Down Syndrome International, Global Down Syndrome Foundation, and the European Down Syndrome Association

Along with that, we need to look closely at the experience that some countries considered “best-practice” have accumulated with Down syndrome over the past 50 years, and share those policies more widely. 

They include Ireland, the United Kingdom, Canada, Australia, New Zealand and some parts of the USA, as well as South Africa and India – all of which maintain vibrant civil society movements to drive policy change. 

This leads to a key point. These gains have been made because of parents and human rights activists NOT because of the government’s investment into basic, evidence-based research for people with Down syndrome.  Still, anyone, even governments, can learn from these experiences.

Greater dissemination of good practices by UN bodies such as the WHO might also be a first step toward sharing this body of experience with the families of people living with Down syndrome in countries that lack strong enabling policies. Another clever idea to avoid confusion of numbers is to require WHO member states to track the number of births of babies with Down syndrome in the WHO statistics

This is all the more important in light of the fact that even as the global proportion of children and adults with Down syndrome may be gradually shifting to lower income countries. These same countries may also lack the years of expertise on early interventions, health care, inclusive schooling systems and work opportunities that have been accumulated in better-resourced societies over the past 50 years. 

Special Olympics Switzerland 2022
Special Olympics, Switzerland 2022

The right to thrive – key principles

So what are the key principles that need to be more widely embraced? 

Firstly, people with Down syndrome have the right to live and thrive as much as anyone else. Doctors should be educated to give parents a choice about termination, in light of the best information about resources that are available. 

However, the focus of public debate on the issue of termination, and with it, a greatly polarized legal and ethical debate is also a big mistake. It diverts attention from the needs of the already  living and breathing children and adults who are too often ignored and shunted aside by society.  

What is needed, instead, is a suite of enabling resources that are adapted across the life-cycle, from access to early childhood interventions to inclusive schools. In later life, support and networks are required to create options for inclusive workplaces and living situations that also foster independence, including social connectivity and options for appropriate, adult intimacy and expressions of sexuality, as this video celebrating World Down Syndrome Day 2022 illustrates.

Suite of interventions

The suite of interventions looks something like this: 

Post-natal support: The extra chromosome was a birth-day surprise! There was no support given, possibly the doctor’s way of announcing that Down syndrome was horrible. I was left to search the internet and order books to try and learn more. This led me and three other women to create a model ‘Premiers-pas’ welcome suitcase for new mothers of babies with Down syndrome, full of little gift items and helpful resources. The aim of the suitcase is to congratulate and support the family in their first steps (in French, premiers pas) of this “extra-ordinary” journey.

Early childhood: Even in high-income Switzerland, with a strong social-service system, as the parent of a toddler with Down syndrome, I had to search for support. I was fortunate to be able to get access to a suite of early childhood interventions including: physiotherapy, ergotherapy, speech therapy and specialist health care but not everyone is as fortunate as us.

Inclusive schools: Inclusive schools are the best way for ensuring that kids with Down syndrome learn to participate in society, and eventually can work and live independently. In Switzerland, each local regional government unit (Canton) is different, while some, like my own Canton of Vaud, have 50-100% inclusive education with a teacher support staff, as of 2022, the Canton of Geneva, the hub of the global health world, is still strongly advising that parents send kids as young as 6, who are speaking, reading, and writing (at their own speed) into institutions. 

This runs contrary to the UN Convention on the Rights of Persons with Disabilities (CRPD) but that doesn’t seem to make a difference.

Teacher training curriculum that considers “inclusive teaching” as the norm – is as important as the school structure itself.  Teachers trained in inclusivity can communicate with children with Down syndrome as well as those with other types of learning difficulties. At the same time, as it’s important for a child to be exposed, as much as possible to “mainstream” school environments, dedicated special needs professionals and programmes can be an important complement. It works both ways, the other kids at the school learn that we are all different, and that difference is the new norm. 

Global evidence-based guidelines exist regarding the right balance, which may vary from setting to setting. Most often, governments and societies are unaware of these or ignore them.  

Speech therapy: One of the hardest things for people with Down syndrome is to be able to express themselves verbally, and to be understood (imagine speaking with a marshmallow in your mouth!!!). Yet, too often, not enough investment is made into this vital skill – and students that struggle can be penalized even more.  This is what happened to my son, again in high-income Switzerland, when he went from having two hours of speech therapy per week to 45 mins – because “he wasn’t making enough progress”!  

If speech and communications aren’t developed at a young age, how can a young adult ever begin to move around independently or hold onto a job in a not closed setting? 

Safe, liveable cities and neighborhoods with opportunities for healthy physical activity and mobility. I’m lucky to have my son picked up by a school taxi in the morning three days a week, for a ‘special education’ school. On the other two days, he goes to his ‘mainstream’ school by himself on the train, walking to school and home again in a village. I can track his movements with the GPS on his iPhone so he is able to gradually expand his autonomy and independent mobility, including small tasks like checking to make sure he has his ticket for the ride, or change to purchase a drink at the kiosk. Keep in mind, however, that such safe, linked-up mobility is not only important for children and adults with Down syndrome – it is critical to healthy societies more generally. 

Health: As we have known about Down syndrome since it was first described medically in 1866, we also know a great deal about its main health conditions. This means that public health systems need to equip parents with a well-documented health check-list to ensure good health practices are available. And as that, too often, is missing, Not all doctors are aware of everything, but digital solutions can fill many gaps. One example is a DSC2U, a new virtual online clinic created by Massachusetts General Hospital only last year to guide parents and doctors alike. It would be great if such a resource, and its related medical guidelines and the health recommendations, could be duplicated much more widely.  

Working: Employers are missing opportunities. Given the right opportunities, training and support, people with Down syndrome can make a very considerable contribution in the workplace – filling many routine jobs with positive energy and an ethic of reliability – in exchange for an offer of “decent” work, pay and real inclusion. Some civil society associations like WorkFit in the UK are making huge inroads on the employment scene, from which other countries could learn. Hiring just one person with Down Syndrome creates a “virtuous chain” which other potential employers observe and imitate, as this great video illustrates, performed by STING, published on World Down Syndrome Day 2021.

Independent living solutions:  The Canadian Down Syndrome Society offers a very diverse array of creative living arrangements and approaches, from independent living to group homes and long-term care homes for those needing more support.  It also incorporates training for independent living based on the innovative Italian approach on Education for autonomy

The main take-home point is this: The sooner you start encouraging autonomy in people with Down syndrome the easier it becomes. Independent living isn’t just a space in a house or apartment to sleep, it’s the ability to make real-life decisions and take control over one’s own life, for example who to live with, where to live, how to live. 

Think about it….

Most of the health and well-being solutions that are absolutely critical to children and adults with Down syndrome – are just as important to a range of children and adults with many other forms of disability – as well as to those of us who consider ourselves completely “normal” and “healthy.”  

These also are the types of educational, health and social solutions that we need to promote across the life cycle, in what WHO has long described as the very definition of good health – as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.”

Conversely – in a world where we see fresh horrors of war and violence unfolding on our television screens every night, it’s worth considering one more point: when was the last time you heard about someone with Down syndrome starting a war – or becoming a serial killer? 

As Michelle Sie Whitten, Executive Director, Global Down Syndrome Foundation, noted in a recent blog, we are really talking about the “Story of Two Syndromes.” Just a few decades ago, she observes, most people with Down syndrome in the United States were placed in institutions, even as infants or young children:

“People considered it impossible for them to learn to speak properly, let alone read or write. Today, the average lifespan of someone with Down syndrome is 60 years old. By and large, people with Down syndrome now live at home (versus an institution). Their IQs have increased 20 points and the overwhelming majority will learn how to read and write. Most are attending public school and some are graduating with a typical degree. There is a handful who have gone on to achieve college degrees. More and more are holding down jobs.”

I’d add one more observation. Most people with Down syndrome, when given the opportunity to be stimulated by education, gainfully employed and live in decent housing within networked communities  – also have the rare capacity to respond to the small daily experiences of life with a smile on their faces, smiles that many of us struggle to maintain throughout our day. Smiles like the ones I saw at that Special Olympics event in Villars. 

Perhaps we need more people like this in the world, not less. 

Jillian Reichenbach Ott

 

Jillian Reichenbach Ott is the mother of a 15-year-old boy with Down syndrome and the focal point of the European Down Syndrome Association (EDSA) for Switzerland’s French-speaking region.

 

Ukrainian child with his dog -displaced by war, in a refugee camp on the Moldova-Ukranian border

There have been 52 attacks on Ukrainian health facilities in the past 25 days, more than two every day, according to the World Health Organization (WHO).

Meanwhile, the health of fleeing refugees, their impact on the health services of neighbouring countries, and the fate of Ukraine’s tuberculosis patients are foremost on healthcare providers’ minds.

“In less than a month, over three million people have left the country and nearly two million have been internally displaced,” said Jarno Habicht, WHO’s Representative in Ukraine.

“This has happened faster than in any previous European crisis. There is no safe place in Ukraine right now, yet we need to ensure that health services are available.”

“The military offensive continues, with a number of cities being entirely isolated – people are running out of food and water, and hospitals might not have electricity,” added Habicht, who has been head of the Ukraine office since 2018.

“Worse still, we have seen many attacks on health workers and health facilities as well as patients. This is happening daily and is unacceptable. So, if you ask me how to describe it, every day things are getting worse, which means every day the health response is becoming more difficult.”

Jarno Habicht, WHO’s Representative in Ukraine (centre)

Banned cluster munitions

According to Bonnie Docherty, a senior advisor for Human Rights Watch, Russian forces have “relied heavily” on cluster munitions, which are banned in most countries in the world, and explosive weapons with wide-area effects.

Cluster munitions, large bombs that contain dozens or hundreds of smaller sub-munitions, were used to attack a hospital in Vuhledar on 24 February in which four civilians were killed, and 10 people including six healthcare workers were injured, wrote Docherty in the online security news outlet, Just Security, on Monday.

Unexploded, the submunitions can lie dormant like landmines, exploding months and years later when picked up by children or farmers, she explains.

However, artillery shells, mortars, rockets, missiles, and enhanced blast (thermobaric) weapons, and aerial bombs, have caused the bulk of the damage in Ukraine, adds Docherty.

Concern for drug-resistant TB patients 

On the eve of World Tuberculosis Day on Thursday, WHO TB experts also expressed concern for Ukrainian TB patients, particularly those with drug-resistant TB.

“Ukraine is one of the 18 high-priority countries in the WHO European region for TB and is on the global list for having a high burden of multidrug-resistant tuberculosis,” Dr Askar Yedilbayev, WHO Europe’s Regional TB advisor, told a media briefing on Monday.

Dr Askar Yedilbayev
Dr Askar Yedilbayev

“Before the war, Ukraine was one of the pioneering countries in response to TB and drug-resistant TB in the WHO European region,” he added.

“However, destroyed health infrastructure, including limited access to TB treatment and public health services, is affecting the provision of essential tuberculosis services, causing significant delays in diagnosis of TB, affecting initiation of TB preventive treatment, and treatment of active TB and MDR TB,” he added.

Shortly before the war, all TB medication had been distributed to regional warehouses and patients had been given one or two months’ supply of medicine, he added. But some of these warehouses had been damaged or were under threat of damage, and there was a need for the “emergency redistribution of procurement of medicines to ensure continuity of treatment”. 

In addition, as Ukraine’s neighbours did not have the same burden of TB disease, they were unlikely to have the medicine to treat large numbers of people with TB.

Yedilbayev appealed for donations to the Global Fund and WHO Foundation to enable the delivery of health services to Ukrainians.

Every second, a Ukrainian child becomes a refugee

Every second, a Ukrainian child becomes a refugee, according to UNICEF and half of the over 3.5 million refugees estimated to have fled to neighbouring countries since 24 February are children under the age of 15.

Almost two million refugees have fled to Poland, according to the WHO. 

“Refugees can be vulnerable to infectious diseases because of lack of health care,  interrupted care in the country of origin, because of exposure to infectious infections and lack of care in transit, and if living conditions are poor in the destination country,” said Yedilbayev.

Image Credits: UNICEF/UN0599222/Moldovan.

Children and adolescents under 15 years represent about 11% of all people with TB globally.

Children and adolescents diagnosed with tuberculosis (TB) will benefit from a set of new guidelines that aim to shorten the treatment plan, expand preventative care, and introduce better diagnostic testing and treatments.

The World Health Organisation (WHO) today released a new set of ‘game-changer’ guidelines where children and adolescents with non-severe forms of drug-susceptible TB will now be treated for four months instead of six months. The guidelines come on the back of World TB Day on March 24, and underscore the fact that children and adolescents have fallen behind adults when it comes to prevention and care associated with the disease. The theme this year for World TB Day is ‘Invest to End TB. Save Lives.’ 

“The WHO guidelines issued today are a game-changer for children and adolescents, helping them get diagnosed and access to care sooner, leading to better outcomes and cutting transmission. The priority now is to rapidly expand implementation of the guidance across countries to save young lives and avert suffering,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme.

Non-invasive diagnostics, shortened treatment plans 

Non-invasive stool samples and rapid molecular diagnostics like Xpert machines are now recommended as the initial TB tests for children and adolescents to make the process less traumatic. 

Children and young adolescents aged under 15 years represent about 11% of all people with TB globally, which means that 1.1 million young people under the age of 15 years are diagnosed with TB every year, and over 225,000 of them lose their lives. 

The Geneva-based organisation also announced that it had recommended the reduction in treatment for non-severe forms of drug-susceptible TB by one-third to just four months instead of six months.

In case of TB meningitis, the treatment regimen has been halved to six months from 12 months to promote a patient-centred approach that will reduce the costs of TB care for children, adolescents and their families. 

Over 60% of children and teens with TB are estimated not to have accessed life-saving diagnosis and treatments in 2020. The number stood at 72% for children under the age of five.

Dr Kerri Viney (left) and Dr Tereza Kasaeva. 

“This [shortening] will allow children and adolescents with less severe forms of TB to resume schooling and their normal lives earlier and shorter treatment will also save costs for affected families and the healthcare system,” said Dr Kerri Viney, team leader for vulnerable populations in the WHO’s Global TB Programme.

The new guidelines also recommend the use of the newest TB medicines – bedaquiline and delamanid – to treat drug-resistant TB in children of all ages, including newborn babies. This means that children with drug-resistant TB will receive a regimen that consists only of oral medicines, regardless of their age.

“There is no longer a need for painful injections that can have serious side effects, including deafness,” said Viney. 

New, more efficient TB vaccine needed 

However, the WHO said that, from lessons learnt during the COVID-19 research, there is a need to catalyse investment and action to accelerate the development of new tools, especially new TB vaccines.

WHO is intensifying efforts to shape the TB vaccines agenda in collaboration with other partners with a high level push this year through a global summit, Kasaeva said.

Currently, the only vaccine available for TB is the BCG vaccine which is “not so effective” and can only protect children in the early ages, Kasaeva told Health Policy Watch.

“We have nine vaccines [which are] quite advanced in our pipeline. We are working actively with new actors and new platforms like mRNA platforms and we can see that there is growing interest for the development of TB vaccines,” she said, adding that it was “quite possible” that the development of new, more effective TB vaccines will be prioritized before 2025.

‘No more excuses’ to invest in ending TB

Global spending on TB diagnostic treatment and prevention services fell from $5.8 billion to $5.3 billion in 2020. This is less than half of the global target of $13 billion annual spending by 2022.

“Investing in the fight against tuberculosis is a no-brainer development target,” said Kasaeva. “No more excuses and delays in prioritizing and investing to end one of the top infectious killers,” she said. 

She added that financing for TB research must more than double to enable the discovery of new tools including vaccines, and to scale up life-saving innovation. “We need to invest in sustaining essential TB services during the COVID-19 pandemic and ongoing conflicts to ensure that gains made in the fight against TB are not reversed.” 

Between 2018 and 2020, 20 million people were treated for TB, half of the five-year target of 40 million people targeted for treatment between the same time period. During the same period, 8.7 million people were provided TB preventive treatment, which is 29% of the target of 30 million people to be reached in 2018-2022.

Kasaeva added that as per studies, “ending TB by 2030 can lead to avoiding 23.8 million tuberculosis deaths and almost $13 trillion in economic losses.”  

Image Credits: Stop TB Partnership, WHO.

Dr Hans Kluge

Mental health practitioners worldwide are warning of a massive wave of pandemic-related mental health issues that many countries are ill-equipped to address.

On Monday, the World Health Organization’s (WHO) Europe office and the government of Greece launched a new European programme to strengthen and improve the quality of mental health services for children and adolescents.

WHO Europe Director Dr Hans Kluge told the launch that suicide was the leading cause of death in children and adolescents aged 10 to 19 living in low- and middle-income countries in the region and that over 4000 young people in this age group had killed themselves in 2015.

 

“Ensuring that all children and adolescents in the region have access to quality mental health services is a moral imperative,” said Kluge, adding that this was as important as childhood vaccinations.

The WHO Europe programme aims to work with member states to encourage them to share knowledge and expertise about how to boost the mental healthcare of children and adolescents, and to support member countries to develop their own strategies and frameworks. It will also “develop a package of tools to measure progress against evidence-based standards”, according to the regional office.

Mental health woes of COVID-19

COVID-19 has exacerbated mental health issues and, during the first year of the pandemic, there was a 25% increase in the global prevalence of anxiety and depression, according to a WHO brief published in early March.

Approximately 140,000 children in the US have lost a parent or guardian to COVID, for example, and are likely to be struggling to come to terms with this loss.

“One major explanation for the increase is the unprecedented stress caused by the social isolation resulting from the pandemic. Linked to this were constraints on people’s ability to work, seek support from loved ones and engage in their communities,” according to the WHO.

“Loneliness, fear of infection, suffering and death for oneself and for loved ones, grief after bereavement and financial worries have also all been cited as stressors leading to anxiety and depression. Among health workers, exhaustion has been a major trigger for suicidal thinking,” it added.

Calls to South Africa’s only mental health helpline, for example, have jumped exponentially during the pandemic – from around 400 to 600 calls a day before COVID-19 to over 2400 calls a day in 2021.

Psychologist Zamo Mbele, a board member of the South African Depression and Anxiety Group (SADAG) that operates the helpline, said that his non-governmental organisation, which is wholly reliant on donations, had been struggling to keep up with demand.

Psychologist Zamo Mbele, a board member of the South African Depression and Anxiety Group (SADAG)

Male violence and mental health

“One of the reasons we’ve seen an increase in our calls is because of COVID, but one of the other reasons is because people who would not previously access health are beginning to recognise that they need help,” said Mbele.

He added that “toxic” manifestations of masculinity – seen in the country’s high levels of domestic violence, road rage and substance abuse – were indications that men, in particular, needed help.

“It’s not as though men only recently starting to struggle with mental difficulties or emotional difficulties,” he added. “But they are just starting to see that the expression of their difficulties is no longer functional to them or to society. It’s no longer as socially acceptable to be violent in order to deal with your depression, or to have a big temper in order to deal irritability or anxiety – or to drink excessively or to spend copious amounts of hours at the gym.

“Instead, we’re beginning to recognise that actually doing a lot of these things is masking a lot of symptoms.”

https://twitter.com/SkosanaDr/status/1505834397391544323

Men and suicide

In the vast majority of countries, men are far more likely to commit suicide than women, which mental health practitioners say is likely to be because men find it harder to ask for help.

This is a worldwide trend, captured by the WHO’s Suicide Worldwide in 2019: Global Health Estimates. The report found that South Africa has the third-highest suicide rate on the African continent. Of the 13,774 suicides reported in South Africa, 10,681 were men in 2913 were women.

Russia, South Korea, the US and Japan also have high suicide rates, particularly amongst men.

However, while there has been an increase in suicidal thoughts during the pandemic, there has not been a global increase in actual suicides – with notable exceptions, such as Austria, and Japan (although there is very little information from LMICs).

Polio vaccinate campaign to target children under 5 across five southern African countries.

Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday.

The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in 30 years was identified in a young child in Lilongwe. 

The case was the first in Africa since the region was certified free of indigenous wild poliovirus in 2020. WHO said that the region’s certification as wild polio-free remains unchanged, as the wild poliovirus strain identified had been “imported” from Pakistan. 

So far, no clear explanation of how the Asian virus strain may have infected an African child who had never traveled outside of the country, has been provided by WHO or Malawi health authorities. Nor has there been any explanation of why it took three months between the time the child was diagnosed and the outbreak was formally declared by WHO.

But the breadth of the new campaign makes it clear the incident has been perceived as a major threat to Africa’s wild polio virus free status – with risks of subtle, silent transmission of the virus much more widely, via contaminated water and sewage, food, or human-to-human contact.

Malawi has since set up an environmental surveillance system for poliovirus in 11 cities across four sites, including the Lilongwe District that encompasses the capital Lilongwe, where the initial, and so far only reported case, was detected, WHO said. 

Asked by Health Policy Watch whether traces of the wild polio virus had also been identified in sewage sources, through the environmental surveillance, WHO did not reply as of publication time.  

Targeting children across four countries – then Zimbabwe

More than 80 million doses will be administered to more than 23 million children under 5 years in a four-round vaccination campaign in five southern African countries, WHO said. 

The first phase of the campaign, beginning this month, will target 9.4 million children across Malawi, Mozambique, Tanzania, and Zambia. Three subsequent rounds – with Zimbabwe joining the campaign- are set for April, June, and July, and aim to reach more than 23 million children with more than 80 million doses of the bivalent Oral Polio Vaccine recommended by the World Health Organization (WHO). 

“Polio is a highly infectious and an untreatable disease that can result in permanent paralysis. In support of Malawi and its neighbours, we are acting fast to halt this outbreak and extinguish the threat through effective vaccinations,” said WHO Regional Director for Africa Dr Matshidiso Moeti. 

“The African region has already defeated wild poliovirus due to a monumental effort by countries. We have the know-how and are tirelessly working to ensure that every child lives and thrives in a continent free of polio.”

Single case of polio in Malawi linked to Pakistan strain

Pakistan is one of two countries where polio remains endemic.

Laboratory analysis has linked the strain detected in Malawi to the one circulating in Pakistan’s Sindh Province in 2019. 

In addition to environmental surveillance, WHO has also been supporting the country to reinforce response measures including risk assessment, and preparations for the vaccination campaigns. A surge team from WHO is working with country-based counterparts, partner organizations, and the government to end the outbreak. 

The WHO team is a part of a broader multi-partner Global Polio Eradication Initiative to support the country.

In an unrelated event,  a vaccine-directed case of polio was also identified in February by Israeli authorities in Jerusalem, also for the first time in 30 years. The infected child is part of an ultra-orthodox Jewish community in which vaccination rates hover at around 50% or less. A vaccination drive also was launched in the city.  

Polio, a viral disease with no cure, can invade the nervous system and can cause total paralysis within hours, particular among children under 5 years. The virus is transmitted from person to person, mainly through contamination by fecal matter or, less frequently, through contaminated water or food, and multiplies in the intestine.

While there is no cure for polio, the disease can be prevented through administration of a vaccine.

Image Credits: Sanofi Pastuer/Flickr, Sanofi Pastuer/Flickr.

environment
Safer and more sustainable food systems – from production to sales in food markets is key to a One-Health Approach.

UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday.

The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership – which now has become a “Quadripartite”.

“The One Health approach aims to sustainably balance and optimize the health of people, animals, ecosystems and the wider environment,” said WHO in a press release. “It mobilizes multiple sectors, disciplines and communities to work together to foster well-being and tackle threats to health and ecosystems. And it addresses the collective need for clean water, energy and air, safe and nutritious food, action on climate change, and contributing to sustainable development.”

The work of the newly expanded alliance will be focused on a One Health Joint Plan of Action, which includes six main action tracks: enhancing countries’ capacity to strengthen health systems under a One Health approach; reducing the risks from emerging or resurfacing zoonotic epidemics and pandemics; controlling and eliminating endemic zoonotic, neglected tropical or vector-borne diseases; strengthening the assessment, management and communication of food safety risks; curbing the silent pandemic of antimicrobial resistance (AMR) and better integrating the environment into the One Health approach.

Increased awareness of One Health

As the world enters the third year of the COVID-19 pandemic, with an estimated cost of $8 to 16 trillion, there is increased awareness and broad recognition of the importance of One Health as a long-term, viable and sustainable approach.  The G7, G20 and UN Food Systems Summit have all given a nod to the approach, along with the increased references by WHO and its partners.

But the hard work of reforming food systems, from production to markets, as well as halting related deforestation and ecosystem destruction, are much more formidable challenges that the organisations have barely begun to face.

Last year saw the Tripartite implement a number of initial initiatives, including on antimicrobial resistance,  a One Health High-Level Expert Panel, and guidance on better management – but not the banning – of wild animal sales in markets – in the wake of the COVID pandemic, whose origins may have emerged from the capture, transport and slaughter of SARS-CoV2 infected wild animals at the Wuhan, China market.

Plan implementation the key challenge

“Now the challenge is implementation: how do we translate our work on the ground to support our Members? And how do we mobilize funding and financing mechanisms to support the Joint Plan for Action?” said FAO Director QU Dongyu, handing over the chair of the Secretariat to WHO.

WHO Director-General Tedros Adhanom Ghebreyesus, said: “We need to build a more comprehensive and coordinated One Health governance structure at global level. We need a strong workforce, committed political will, and sustained financial investment. We need to develop a more proactive way of communicating and engaging across sectors, disciplines and communities to elicit the change we need.”  (WHO)

Image Credits: Michael Casmir/Pierce Mill Media.

Dental procedures produce a hefty amount of carbon emissions.

In honour of World Oral Health Day, 20 March, three leading voices from the World Dental Federation highlight the unexpected linkages between the health of your mouth and that of the planet.

It will come as a surprise to most people that the healthcare sector has a significant environmental impact. Healthcare systems are responsible for around 5%  of global greenhouse gas emissions, of which oral healthcare is an important contributor. Indeed, if the healthcare sector was a country, it would be the fifth largest greenhouse gas emitter on the planet.

Oral healthcare contributes to this environmental burden with air pollution arising from the release of CO2 associated with travel and transport, the incineration of waste, the greenhouse gas impact of anesthetic gases such as nitrous oxide and the high consumption of water.

Specific to dentistry, the most routine procedures, all come with a hefty carbon price tag. 

Tooth-coloured fillings for instance, produce around 15 kilograms of CO2eq (carbon dioxide equivalent) per procedure, according to Public Health England, whose National Health Service has done some of the most extensive carbon footprint modeling of healthcare delivery in the world.

A single root canal treatment, meanwhile, produces 23 kilograms of CO2eq, dentures between 58 and 71 kilograms CO2eq.

Use of the anesthetic gas nitrous oxide (laughing gas), in a procedure, meanwhile, is responsible for 119 kilograms CO2eq. 

Nitrous oxide N2O, the most commonly used inhalation dental anesthetic, is a greenhouse gas with far more climate warming potential than CO2. Just one kilogram of nitrous oxide is equivalent to 298 kilogrammes of CO2 and 25 kilograms of methane – another powerful greenhouse gas. 

Meanwhile, silver amalgam fillings contain mercury. While more and more rarely used today, and still considered safe for dental treatments, there is an environmental impact through the release of residual mercury into sewage during procedures, as well as throughout its life cycle. 

Prevention is better than cure  

oral health
Ways to maintain good oral health.

The dental industry has a collective responsibility to reduce these impacts – while also expanding access to oral healthcare. How can we do both? 

One simple solution is to look at how we can best minimize what we might label as “avoidable” oral procedures.  

Prevention is always better than cure and it is the most impactful and practical way of reducing the need for clinical interventions and their associated environmental impacts. 

This is best achieved through the promotion of good oral hygiene, a healthy diet and the avoidance of smoking.  When treatment is required, oral healthcare also should focus on the provision of durable fillings, using high quality products and materials that will last longer and/or require fewer replacements.

Legislation around water fluoridation for instance, complemented by targeted public health policies can help prevent tooth decay (caries) and ultimately cavities. The recent banning of  TV and online advertising of junk food in the UK before 9pm is an indirect example of encouraging better diet. So too the campaign by UK footballer Marcus Rashford to promote healthier school lunches.

At the same time, while many dental problems such as caries and periodontal (gum) disease are common preventable diseases, no amount of prevention can make them go away entirely. 

There will always be a need for accessible dental check-ups and treatments to facilitate good oral health. And it remains important to expand access to such treatments among disadvantaged groups as well as in many low- and middle-income countries so as to reduce inequalities in healthcare provision. 

Less trips to the dentist would also mean less travel and water consumption

Dental procedures require a lot of water, which can be reduced by practicing good oral healthcare.

Oral healthcare has higher levels of patient and staff transport than other medical specializations and this is partly due to the need for regular oral health maintenance, whereas other specializations tend only to treat illness.

In the UK for instance, staff and patient commuting and travel accounts for approximately two thirds of all emissions from the oral healthcare sector and about eight per cent of the total UK NHS air pollution attributable to travel. This can be reduced significantly, through the maintenance of good oral health, that requires fewer interventions and consequently fewer trips to the dentist.

Simple transport habit changes can have a great impact. For example, in October 2021 the Sustainability Committee at Harvard School of Dental Medicine (HSDM) implemented a `Step Challenge´ that encouraged staff, students and faculty to walk, or take public transport rather than drive during that month. They amassed over one million steps in total, preventing the release of approximately 0.28 metric tons of CO2.

The practice of dentistry and personal oral healthcare is a significant consumer of water. As a conservative estimate, a bathroom tap delivers about four litres/minute. If we estimate that half the world population cleans their teeth once a day and runs the tap for one minute, the daily global water usage equates to 6,400 Olympic swimming pools. This figure is in addition to undocumented water consumption up and down the oral healthcare manufacturing and distribution supply chain.

Reducing dental use of single use plastics and packaging 

Measures to reduce carbon footprint in dental offices.

So what measures can be taken at the dentist office to reduce the carbon footprint of dentistry procedures that are nonetheless essential to good oral health? 

The use and consequent disposal of single use plastics for many procedures is one of the biggest contributors to the environmental footprint of healthcare generally – and that holds true for dentistry as well. 

Among single-use plastics, in fact it is the packaging in which the needles, gloves and other oral healthcare products are encased that is the single largest contributor to such waste in the dental industry, with over 90 %  ending its life cycle in an incinerator or a landfill. 

A more thoughtful approach to the design of such packaging – from the plastics content, manufacture and transport, to the potential for reuse, recycling or biodegradability, is therefore one obvious starting point in reducing the carbon footprint of the typical dentist’s office. 

This is particularly important  because packaging, as such, is not “contaminated” biomedical waste that needs special treatment, post-procedure. 

This requires greater engagement with consumers and waste management companies to segregate, collect and recycle uncontaminated clinical single use plastics (SUPs) as a valuable commodity. It also involves the design and development of more plastic items made from mono-polymer plastics that can be readily recycled. 

The Flexible Plastics Consortium which represents 34 European companies looking for better plastics content and design solutions for packaging is a good example of how this might work in practice.

The United Kingdom’s Plastics Pact is another good example: it has set targets with the goal of 100% of plastic packaging to be reused, recycled or compostable by 2025.

Major challenges in managing single use plastic waste from oral healthcare

Many single use dental items end up in the waste bin, including gloves, aprons, masks.

Once the box is opened, many of the everyday products used in dentistry are only briefly used and then end up in the waste bin.  These single-use plastic (SUP) items range from personal protective equipment (aprons, gloves and masks) and other disposable sundries (the mouth-rinse cup or the dental suction tube).

SUP biomedical waste requires more specialized management  – since these are contaminated with blood and other bodily fluids from oral health procedures. 

The high safety and quality requirements for these products to be legally compliant, is often incompatible with recycling and materials recovery. The complex nature of items assembled from different plastics also makes recycling difficult, as does the prevailing view that plastic is simply waste and is not considered a valuable resource.

Still there are many attempts at finding solutions around the world. 

These include incentivization schemes and professional education courses that can help manufacturers to design products that can be safely treated and reprocessed, as well as sensitizing dental practitioners to different waste streams, and the treatment they require. 

Initiatives like the development of  a competency-based dental waste management course being undertaken at the Copperbelt University in  Zambia are a step in the right direction.

Even so, the lack of good technological solutions for the appropriate collection, disinfection/sterilization and subsequent recovery or reprocessing of single use plastics used in biomedical procedures  remains an ongoing barrier. We need product research to come up with safe, sustainable solutions for a circular economy, including in the healthcare sector, and governments to adopt supportive   policies.

Assessing the environmental impacts of oral healthcare as a first step

It is important to understand the environmental impacts of materials used in healthcare.

A better understanding of the environmental impacts of products and materials used in healthcare systems, from procurement to disposal, is key to any of these measures. 

Solutions proposed have included more life cycle analysis for all materials used in the healthcare supply chain and the development of a credible ‘sustainability index’ to inform medical supply purchasers about the sustainability credentials of a product.

The index could potentially include information on environmental sourcing, ethical manufacturing, supply chain distribution and procurement.

This World Oral Health Day we can celebrate the fact that the oral health sector has recognised that it has a vital role to play in healthcare-related climate change mitigation. That is the first step.

The next ones will be more challenging and will need ‘teeth’. The FDI World Dental Federation´s Code of Good Practice, which is to be launched later this year, following an extensive consultation with the sector, will be a good starting point for ensuring healthy mouths also help to produce a healthier planet.

Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco.

Nicolas Martin is the Chair of the FDI Sustainability in Dentistry Task Team. He is also Clinical Professor in Restorative Dentistry in the School of Clinical Dentistry, at the University of Sheffield, UK.

Steven Mulligan is a Member of the FDI Sustainability in Dentistry Task Team. He is also a Clinical Lecturer in Restorative Dentistry in the School of Clinical Dentistry, at the University of Sheffield, UK.

Image Credits: Mass Communication Specialist Seaman Apprentice Brian H. Abel/Flickr, FDI World Dental Federation , Jan Fidler/Flickr, World Dental Federation , Mass Communication Specialist 3rd Class Everett Allen/Flickr.

COVID-19 patient in severe state in Chernivtsi, Ukraine
Lifesaving oxygen flows into the lungs of a COVID patient in Chernivtsi, southwest Ukraine before the start of the recent Russian invasion. Whether its due to COVID or conflict, oxygen supplies fall short in many parts of the world.

From patients lying in the parking lots of hospitals, in the back seats of cars suffocating as their family members searched frantically for oxygen in India during its second wave of COVID last year, to the inability to receive emergency care amidst constant bombing and shelling in current war-torn Ukraine, global health experts and leaders are desperately searching for ways of improving the global oxygen supply.  

At a media briefing on the issue Thursday, speakers emphasized the need for both access to oxygen on the ground and more funding to the WHO co-sponsored Access to COVID-19 Tools Accelerator (ACT-A), which is attempting to beef up oxygen supplies in low and middle-income countries. 

“Oxygen has been treated for too long like a commodity, treated as something that must be delivered,” said WHO Executive Director of Health Emergencies Programme Dr Mike Ryan, speaking at the briefing, cosponsored by the Act Acccelerator and Unitaid. 

But “oxygen is a capability, not a commodity,” he stressed. 

Rethinking oxygen’s lifesaving capacities 

Mike Ryan, Executive Director, Health Emergencies Programme; World Health Organization

Ryan and others made the case for rethinking oxygen as a health tool that requires not only a sustainable supply at a country level, but an entire ecosystem of supply and maintenance  technology and infrastructure.

Its role – and the chronic lack of capacity in many countries – has been underscored by COVID – and again in the very different setting of the Ukraine crisis – where the lack of access for people ranging from COVID patients to mothers in birth and children with pneumonia has prompted widespread alarm.  

Oxygen remains a critical component of the global COVID-19 response – 75% of patients hospitalized for COVID-19 can be treated with oxygen alone – without any further advanced care. Yet the current global supply of oxygen does not meet needs for both COVID-19 and other serious illnesses. 

“COVID didn’t cause [the oxygen shortage], COVID uncovered this. COVID laid bare, tore away the bandages from some very old wounds,” said Ryan. 

UNITAID Commits $56 million to boost access to global medical oxygen supply

Robert Matiru, Chair, ACT-A Oxygen Emergency Taskforce & Director Programmes, Unitaid

The ACT-A Strategic Plan and Budget for 2022 has identified a funding deficit of $1 billion for oxygen supplies worldwide for this year alone. As a first step to closing that gap, Unitaid has announced that it will invest $56 million to increase access to medical oxygen both for short-term needs related to  COVID-19 as well as for the longer term – as a critical foundation for fighting future pandemics. 

The Unitaid pledge builds on the $50 million USAID has committed in funding for oxygen as pledged at US President Joe Biden’s Global COVID-19 Summit in September 2021. 

Four Unitaid-funded projects, designed to address global inequities in oxygen access, will be implemented by The Alliance for International Medical Action (ALIMA), the Clinton Health Access Initiative (CHAI), Partners in Health (PIH), and the WHO Health Emergencies Programme. 

These will also support the work of the ACT-A Oxygen Emergency Task Force by ensuring access to more affordable oxygen solutions such as bulk liquid oxygen, oxygen generation systems, and other important oxygen equipment. 

Unitaid called on donors, including governments, foundations, and private sector partners to join in the efforts.  

“Our call here is not just for the present, for this pandemic, but to recognize that donors and funders that come forward and step forward, over and above the generous contributors to date, will help drive a more sustainable ecosystem and [deliver] essential medicines to countries that are lacking it,” said Robert Matiru, Chair of the ACT-A Oxygen Emergency Taskforce and Director of Programmes at Unitaid. 

Children with pneumonia unrecognized victims – 40% of hospitals in some African countries lack oxygen

oxygen
Numerous countries are facing oxygen shortages, while readily available oxygen products are in short supply.

Children are among the unrecognized victims of the lack of oxygen supplies – with childhood pneumonia still one of the biggest killers of under-fives. 

Accounting for almost a million deaths a year, the highest burden is in sub-Saharan African and South-East Asian countries where children face a double whammy of disease from both the lack of preventive treatments, like vaccinations, along with exposure to heavy indoor air pollution from the open burning of coal, biomass and other such fuels. 

But an estimated 20 to 40% of these deaths are preventable with increased availability of oxygen therapy. 

The shortage is particularly acute in low-income sub-Saharan African countries such as Tanzania, Sierra Leone, Liberia, and Gambia, where 40% of health facilities had no access to oxygen and other basic life saving supplies, said Atul Gawande of the United States Agency for International Development (USAID).   

COVID has led to big surges in needs 

Daily medical oxygen need for COVID-19 as of 16 March 2022

Along with the chronic shortages, COVID led to a major surge in oxygen needs. 

Low and middle-income countries (LMICs) need at least 23 million cubic meters of oxygen every day, just to treat COVID patients alone, according to the PATH COVID-19 Oxygen Needs Tracker

On the brighter side, the pandemic has brought a long-ignored aspect of health capacity in LMICs more to  the forefront. 

USAID is currently working in 11 countries to build ‘oxygen ecosystems’ to support oxygen therapy for pneumonia patients, COVID patients, and others, Gawande said.  

Countries like Ghana now have oxygen generating capacity that can support up to 300,000 patients per day, per year. 

Gawande noted that the oxygen ecosystem includes liquid oxygen cylinders and concentrators, as well as the clinical engineering and technical assistance to use the technology. 

But expanding this initiative to other countries still needs more funding.  

Atul Gawande, USAID

“As the Omicron variant abates, I think we’re all starting to feel that we can catch our breath. Oxygen demand may be lower right now. But it is the time that we have to make these investments to enable this kind of [sustainable] capacity.” Gawande said.  

Oxygen ‘natural security’ and ‘high-return’ health investment  

Leith Greenslade, Founder/CEO, JustActions & Coordinator, Every Breath Counts Coalition

While the recent funding commitments are a positive sign, ‘it is not enough to fund protection’, said Leith Greenslade of the Every Breath Counts Coalition

“It took a pandemic of respiratory infection to wake up the world,” she pointed out.

In the past year, about $700 million was invested into the ACT-A Oxygen Emergency Task Force, which has worked in LMICs to prevent oxygen shortages – jump-starting a more focused response. 

But so far, only a handful of governments – including the United States, Germany, Canada, and France – have borne the funding burden. 

“But most of the G-20 nations have not stepped up to invest in oxygen,” she charged.  

Greenslade appealed to donors to see oxygen as a high priority for three reasons: the moral obligation to flatten the COVID-19 curve; oxygen as a “national security” issue in moments of crisis; and finally, oxygen as a high-return health investment that will keep on saving lives beyond the pandemic. 

“When hospitals run out of oxygen, we have seen strikes and civil unrest in quite a few low- and middle-income countries,” she pointed out. 

“How many more deaths before this is over will largely depend on access to oxygen and critical care in the countries where the disease is greatest and the health systems are weakest,” she declared.

Image Credits: Mstyslav Chernov/ Wikimedia Commons, UNICEF/Ralaivita, PATH, Every Breath Counts .

Pfizer’s Paxlovid, an oral antiviral approved by the US FDA in December, has shown 90% efficacy in preventing mortality among those who take it in the first few days of infection.

A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. 

The MPP-brokered sublicences follow on from an agreement between MPP and Pfizer in November 2021 to supply generic versions of Pfizer patented main drug ingredient, nirmatrelvir, at cost, to countries that represent about 53% of the world’s population.

However, activists quickly slammed with the new accord – saying that it would take up many months to actually set up the generic production lines of the game-changing oral drug, which in clinical trials, reduced COVID mortality by 90% among high risk groups.  

Mapping of the MPP-brokered licenses awarded for manufacture of a generic version of Paxlovid

In a joint letter to Pfizer CEO Albert Bourla, delivered Wednesday, a consortium of 100 activist groups, including Amnesty International and Oxfam, said that Pfizer should immediately dedicate two-thirds of the company’s available patented drug supply to low- and middle-income countries, “where there is a proportionate need.” 

“At present, Pfizer has preferentially sold all of its Paxlovid doses from the first half of 2022 to a handful of high-income countries, and has tentatively promised to supply only 10 million courses of treatment of LMICs,” stated the Health Global Access Project (Health Gap), one of the signatories to Wednesday’s letter,  in a follow-up blog posted online just after the MPP announcement.

The activists also have slammed the still high price of the new drug in upper-middle and high income countries, saying that this also creates barriers to access. The United States is paying about $530 a day for a five-day course, although Pfizer has committed to a 3-tiered pricing system with lower costs to less affluent countries. 

 “This announcement will do nothing to eliminate the monopoly Pfizer maintains over unlicensed countries – all high-income and almost all upper-middle income countries, representing 47% of the world’s population and historically experiencing the highest rates of COVID-19 infection,” added Brook Baker, Health Gap Senior Policy Analyst and a Professor at Northeastern University School of Law.  

MSF –  A ‘positive step’ forward 

Médecins Sans Frontières sounded a more positive note,  however, saying that the Pfizer agreement with 35 generics manufacturers in 12 countries represents a “positive step toward addressing the ongoing access challenges for this COVID treatment.  However, the limitations of the deal remain concerning.”

“The limited global supply from the US corporation Pfizer has so far largely been bought up by a number of high-income countries. It is estimated that generic manufacturers will not be able to bring supply to the market until 2023,” stated MSF.

Replying to the criticism, an MPP spokesperson stressed that the new agreement “includes all low and lower-middle-income countries as well as some upper-middle income countries in Sub-Saharan Africa that have transitioned to upper-middle-income status in the past five years.

The 53% of the world’s population covered by the licenses, “which is equivalent to about 4.1 billion people. As with all our licences we will continue to explore opportunities to broaden geographic scope, where possible,” the MPP spokesperson added.

Design of MPP agreement  

According to MPP, the non-exclusive sublicence deals will allow generic manufacturers to produce the raw ingredients for Paxlovid’s main active ingredient, nirmatrelvir, and/or the finished drug itself, which is co-packaged with a common HIV drug, ritonavir. 

It said that six companies will focus on producing the drug substance, nine companies will produce the finished drug product and the remainder will do both. 

The manufacturers are based in 12 countries including: Bangladesh, Brazil, China, Dominican Republic, Jordan, India, Israel, Mexico, Pakistan, Serbia, Republic of Korea, and Vietnam. 

“A licence has also been offered to a company in Ukraine, the offer will remain available to them as they are not able to sign due to the current conflict,” MPP said.

The deal signed between MPP and Pfizer in November 2021 established the terms and conditions, for the generic licenses, MPP added. Following that, “The requests for sublicences from generic producers were reviewed by MPP and presented to Pfizer,” for its approval – one of the conditions of the sale. 

Pfizer will not receive royalties from sales of nirmatrelvir from the MPP-negotiated sublicensees for as long as COVID-19 remains classified as a Public Health Emergency of International Concern by the World Health Organization, MPP added. 

Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector.

“Nirmatrelvir is a new product and requires substantial manufacturing capabilities to produce, and we have been very impressed with the quality of manufacturing demonstrated by these companies,” said Charles Gore, MPP Executive Director. “Furthermore, 15 companies are signing their first licence with MPP, and we warmly welcome our new generic manufacturing partners.”

“We have established a comprehensive strategy in partnership with worldwide governments, international global health leaders and global manufacturers to help ensure access to our oral COVID-19 treatment for patients in need around the world, said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “The MPP sublicensees and the additional capacity for COVID-19 treatment they will supply will play a critical role to help ensure that people everywhere, particularly those living in the poorest parts of the world, have equitable access to an oral treatment option against COVID-19.”

Image Credits: Pfizer , Medicines Patent Pool .